A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Status:
Completed
Trial end date:
2012-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid in
the treatment of bone metastases in subjects with advanced breast cancer.